Decoding Fertility Challenges Through Immunology: Experts Call for New Solutions to Tackle Low Birth Rates
Desk
korocamia@naver.com | 2026-11-18 10:20:21
BUSAN — As the demographic crisis of low birth rates and a shrinking population escalates into a critical public health concern, medical experts emphasize the urgent need to integrate reproductive immunology into fertility research while simultaneously fostering a supportive social environment for pregnancy and childbirth.
The International Society for Immunology of Reproduction (ISIR) recently hosted the 16th ISIR International Congress at BEXCO in Busan, drawing approximately 400 reproductive medicine specialists from around the globe to discuss strategies for addressing the demographic challenge.
Busan holds deep historical significance as a city where medical pioneers dedicated themselves to preserving life during the trials of the Korean War. Notably, the late Dr. Kwak Lim-mo helped establish the Busan Medical Association and served as the director of Gyeryong Hospital, contributing significantly to the advancement of obstetrics and maternal health. To honor this legacy of reverence for life and academic heritage, ISIR President Dr. Younghae Kwak and Kunga Group CEO Eun-ah Kwak joined hands. CEO Kwak personally proposed, hosted, and sponsored the Busan conference to explore medical solutions for the demographic crisis and expand international academic exchanges.
"Patients who had previously given up on pregnancy after conventional treatments failed have successfully given birth through reproductive immunological evaluations and therapies," said Dr. Younghae Kwak. "Ongoing research is vital to uncovering new root causes and developing innovative treatment methods."
Dr. Kwak, a professor of obstetrics and gynecology at Rosalind Franklin University of Medicine and Science in the United States, has spent 40 years caring for patients and conducting research in reproductive immunology. Recently, ScholarGPS ranked her institution as the world’s No. 1 research organization in reproductive immunology, while Dr. Kwak herself was named among the top 7 individual researchers globally.
Complex Challenges: Infertility, Miscarriage, and Pregnancy Complications
As the average age of pregnancy and childbirth rises, the nature of challenges faced by infertile patients has evolved. Even when attempting in vitro fertilization (IVF), patients often struggle to retrieve sufficient eggs or face embryo implantation failures. Beyond the difficulty of conceiving, managing pregnancy complications such as miscarriages and preeclampsia has become increasingly common.
Dr. Kwak explained that understanding these complex fertility issues requires examining the immune system's role throughout the reproductive process. "Because the immune system is intricately involved in embryo implantation and the maintenance of pregnancy, analyzing causes from an immunological perspective offers novel approaches to problems that were previously difficult to resolve with standard treatments," she noted.
The management of pregnancy in women with autoimmune diseases is another focal point of reproductive immunology. Dr. Kwak advised, "Women with lupus or rheumatic diseases must evaluate their disease activity and medication regimens prior to conception, while carefully considering how potential disease flares during pregnancy could affect the maintenance of the pregnancy."
Translating Immunological Findings Into Clinical Practice
The congress also highlighted studies analyzing ovarian aging, inflammation, and preeclampsia through an immunological lens. Dr. Kwang-yul Cha, global research director at CHA University and CHA Bio Group, delivered a presentation introducing concrete strategies for securing "K-Cells" and exploring their potential applications in ovarian aging research. Director Cha is a protégé of the late Dr. Hyun-mo Cha—a former professor and dean of the Yonsei University College of Medicine and the father of Dr. Younghae Kwak. Through this connection, Dr. Kwak and Director Cha are continuing a cross-generational academic partnership rooted in obstetrics and gynecology.
Preeclampsia is a serious condition characterized by the onset of hypertension after 20 weeks of gestation, frequently accompanied by proteinuria or organ dysfunction. It poses severe maternal risks, including seizures and organ damage, alongside fetal growth restriction and premature birth risks.
Current studies are investigating how the maternal immune system adapts during pregnancy and how immune cell dysfunction correlates with pregnancy complications to unravel the pathogenesis of preeclampsia. "When disruptions occur in the interactions between immune cells and placental cells during placental development, it can impair placental vascular development and lead to preeclampsia," Dr. Kwak explained. "Elucidating these immunological mechanisms helps in the early prediction of high-risk pregnancies and the identification of novel therapeutic targets."
Building an Environment Supportive of Fertility Treatment and Childbirth
Experts stress that resolving the low birth rate crisis cannot be achieved through efforts within the fertility medical sector alone.
"Although birth rates have rebounded slightly, they still fall short of the 2.1 total fertility rate required to sustain population stability," Dr. Kwak pointed out, noting that natural population decline—where deaths outnumber births—persists. "We must move away from uniform childbirth encouragement or penalizing those who do not have children. Instead, we need to analyze the causes from medical, social, and economic viewpoints and lower realistic barriers."
Meanwhile, the ISIR hosted an open forum during the congress to share insights and listen to the hardships individuals face throughout pregnancy and childbirth. The society plans to maintain active engagement with actual infertile patients and their families moving forward.
"Because infertility patients are prone to exhaustion over long treatment journeys, support from family, friends, and the local community is crucial," Dr. Kwak concluded. "To bridge our research achievements directly into clinical practice, we will continue to listen closely to the challenges faced by patients and reflect them in our research."
[ⓒ Global Economic Times. 무단전재-재배포 금지]
WEEKLY HOT
- 1From Dried Squid to Microchips: South Korea Becomes Fourth Nation to Hit $1 Trillion in Annual Exports
- 2South Korea’s H1 Public Procurement Contracts Dip 5.6% in First-Ever Contraction
- 3“If the Haves Don’t Do It, Who Will?”… Chairman Choi Shin-won’s ‘Sharing’ Elevates the Dignity of Korean Capitalism
- 4South Korea Weighs Budget Hike to Combat AI-Assisted Exam Cheating
- 5Daehwa Pharma Renews Push for Domestic Insurance Coverage of Oral Cancer Drug Liporaxel After Decade-Long Hurdle
- 6Apple Pay’s Expansion in South Korea Raises Fee Concerns, Putting Samsung Pay’s Free Model in Question